Track topics on Twitter Track topics that are important to you
WEDNESDAY, March 8, 2017 -- Dental care was decidedly primitive back in the time of the Neanderthals. But new research suggests these long-gone relatives of humans already had 21st century solutions t...
Recro Pharma has unveiled positive results from its second of two Phase III clinical trials assessing intravenous (IV) meloxicam for the treatment of acute postoperative pain.
Recro Pharma Inc. (NASDAQ:REPH) gained $1.54 (20%) to $9.30 after it said IV meloxicam (N1539) met the primary endpoint of a second Phase III study to treat acute postoperative pain. The therapy signi...
MALVERN, Pa., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on products for hospital and other acute care setti...
This study determined whether meloxicam in nanocapsules modifies stomach and liver damage caused by free meloxicam in mice. Male Swiss mice were treated with blank nanocapsules or meloxicam in nanocap...
OBJECTIVE To determine pharmacokinetics after IM and oral administration of a single dose of meloxicam to American flamingos (Phoenicopertus ruber). ANIMALS 14 adult flamingos. PROCEDURES Flamingos we...
A new method of analysis has been developed and validated for the determination of meloxicam in egg whites and yolks. Following a liquid extraction for the whites and a solid phase extraction for the ...
Dry powder inhalers (DPIs) have been among the fastest developing inhaler forms in the past decades. Researches are focusing on the formulation of carrier-free powders to obtain a higher deep-lung dep...